Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Nomax Inc
WARNING LETTER
•Nomax Inc•October 27, 2016

Nomax Inc – FDA Warning Letter, Oct 27, 2016

Record Details

An FDA inspection of Nomax Inc. in St. Louis, MO, from October 18-27, 2016, revealed significant violations of the Quality System (QS) regulation (21 CFR Part 820) for its manufactured/repackaged devices, including contact lens cases and Red Cote Disclosing tablets. The firm's devices were deemed adulterated under section 501(h) of the Act. Key deficiencies included the failure to adequately review, evaluate, and investigate device complaints (21 CFR 820.198(c)), and inadequate documentation of corrective and preventive action activities and results (21 CFR 820.100(b)). Management review results and dates were not documented from January 2015 to September 2016 (21 CFR 820.20(c)). The firm also failed to document acceptance activities for a Class II device, FlatPacks (21 CFR 820.80(e)), did not maintain a Device History Record for this product (21 CFR 820.184), and did not evaluate potential suppliers based on specified requirements (21 CFR 820.50(a)(1)). Although Nomax Inc. provided a response, the FDA expressed concerns regarding the timeliness of personnel training, gap analysis for FlatPack products, and a full audit. The letter mandates prompt corrective action, a written response within fifteen business days detailing steps taken, prevention plans, and a timetable for systemic corrections. Failure to comply may lead to regulatory actions such as seizure, injunction, civil money penalties, and impact on government contracts and device approvals.

Company
Nomax Inc
Inspection date
October 27, 2016
Product type
Devices
Office
Kansas City District Office
Person
  • Cheryl A. Bigham (Division Director)
View Company Profile

ID · 79e9daea-cca5-4615-8ae9-1abad26ab361

Violation Codes9
21 U.S.C. 321(h)21 U.S.C. 351(h)21 CFR 82021 CFR 820.198(c)21 CFR 820.100(b)21 CFR 820.20(c)21 CFR 820.80(e)21 CFR 820.18421 CFR 820.50(a)(1)

Full citation text and observation details available on the Dashboard.

Other documents for Nomax Inc
  • 483 - 2022-12-02December 2, 2022
  • 483 - 2018-02-01February 1, 2018
  • EIR - 2018-02-01February 1, 2018
  • EIR - 2016-10-27October 27, 2016

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Nomax Inc
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.